Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CANNABINOID RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 637 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ueda, N; Liu, Q; Yamanaka, K
      Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
    2. Philippoussis, F; Przybytkowski, E; Fortin, M; Arguin, C; Pande, SV; Steff, AM; Hugo, P
      Derivatives of monoglycerides as apoptotic agents in T-cells

      CELL DEATH AND DIFFERENTIATION
    3. Bezuglov, V; Bobrov, M; Gretskaya, N; Gonchar, A; Zinchenko, G; Melck, D; Bisogno, T; Di Marzo, V; Kuklev, D; Rossi, JC; Vidal, JP; Durand, T
      Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Salio, C; Fischer, J; Franzoni, MF; Mackie, K; Kaneko, T; Conrath, M
      CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn

      NEUROREPORT
    5. Brett, R; Mackenzie, F; Pratt, J
      Delta(9)-tetrahydrocannabinol-induced alterations in limbic system glucoseuse in the rat

      NEUROREPORT
    6. Murillo-Rodriguez, E; Cabeza, R; Mendez-Diaz, M; Navarro, L; Prospero-Garcia, O
      Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor

      NEUROREPORT
    7. Valjent, E; Pages, C; Rogard, M; Besson, MJ; Maldonado, R; Caboche, J
      Delta 9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivodepends on dopaminergic transmission

      EUROPEAN JOURNAL OF NEUROSCIENCE
    8. Azad, SC; Marsicano, G; Eberlein, I; Putzke, J; Zieglgansberger, W; Spanagel, R; Lutz, B
      Differential role of the nitric oxide pathway on Delta(9)-THC-induced central nervous system effects in the mouse

      EUROPEAN JOURNAL OF NEUROSCIENCE
    9. Huang, MJ; Leszczynski, J
      An ab initio theoretical study of the stereoisomers of tetrahydrocannabinols

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    10. Montgomery, JM; Madison, DV
      The grass roots of synapse suppression

      NEURON
    11. Mendelson, WB; Basile, AS
      The hypnotic actions of the fatty acid amide, oleamide

      NEUROPSYCHOPHARMACOLOGY
    12. Berdyshev, EV; Schmid, PC; Krebsbach, RJ; Schmid, HHO
      Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells

      FASEB JOURNAL
    13. Lewis, R
      Researchers focus on endocannabinoid

      SCIENTIST
    14. Bonechi, C; Brizzi, A; Brizzi, V; Francioli, M; Donati, A; Rossi, C
      Conformational analysis of N-arachidonylethanolamide (anandamide) using nuclear magnetic resonance and theoretical calculations

      MAGNETIC RESONANCE IN CHEMISTRY
    15. Lichtman, AH; Poklis, JL; Poklis, A; Wilson, DM; Martin, BR
      The pharmacological activity of inhalation exposure to marijuana smoke in mice

      DRUG AND ALCOHOL DEPENDENCE
    16. Ferraro, L; Tomasini, MC; Cassano, T; Bebe, BW; Siniscalchi, A; O'Connor, WT; Magee, P; Tanganelli, S; Cuomo, V; Antonelli, T
      Cannabinoid receptor agonist WIN 55,212-2 inhibits rat cortical dialysate gamma-aminobutyric acid levels

      JOURNAL OF NEUROSCIENCE RESEARCH
    17. Zhou, D; Song, ZH
      CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells

      JOURNAL OF NEUROSCIENCE RESEARCH
    18. Hajos, N; Ledent, C; Freund, TF
      Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus

      NEUROSCIENCE
    19. Dean, B; Sundram, S; Bradbury, R; Scarr, E; Copolov, D
      Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated withschizophrenia and cannabis use

      NEUROSCIENCE
    20. Malan, TP; Ibrahim, MM; Deng, HF; Liu, Q; Mata, HP; Vanderah, T; Porreca, F; Makriyannis, A
      CB2 cannabinoid receptor-mediated peripheral antinociception

      PAIN
    21. Abood, ME; Rizvi, G; Sallapudi, N; McAllister, SD
      Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

      NEUROSCIENCE LETTERS
    22. Cesa, R; Mackie, K; Beltramo, M; Franzoni, MF
      Cannabinoid receptor CB1-like and glutamic acid decarboxylase-like immunoreactivities in the brain of Xenopus laevis

      CELL AND TISSUE RESEARCH
    23. Gregg, TR; Siegel, A
      Brain structures and neurotransmitters regulating aggression in cats: Implications for human aggression

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    24. van der Stelt, M; Veldhuis, WB; van Haaften, GW; Fezza, F; Bisogno, T; Bar, PR; Veldink, GA; Vliegenthart, JFG; Di Marzo, V; Nicolay, K
      Exogenous anandamide protects rat brain against acute neuronal injury in vivo

      JOURNAL OF NEUROSCIENCE
    25. Maingret, F; Patel, AJ; Lazdunski, M; Honore, E
      The endocannabinoid anandamide is a direct and selective blocker of the background K+ channel TASK-1

      EMBO JOURNAL
    26. Garcia, OP; Murillo-Rodriguez, E; Gonzalez, DM; Diaz, MM; Moctezuma, JV; Navarro, L
      Vegetal marijuana, animal marijuana

      SALUD MENTAL
    27. Muller-Vahl, KR; Koblenz, A; Jobges, M; Kolbe, H; Emrich, HM; Schneider, U
      Influence of treatment of Tourette syndrome with Delta(9)-tetrahydrocannabinol (Delta(9)-THC) on neuropsychological performance

      PHARMACOPSYCHIATRY
    28. Matias, I; Bisogno, T; Melck, D; Vandenbulcke, F; Verger-Bocquet, M; De Petrocellis, L; Sergheraert, C; Breton, C; Di Marzo, V; Salzet, M
      Evidence for an endocannabinoid system in the central nervous system of the leech Hirudo medicinalis

      MOLECULAR BRAIN RESEARCH
    29. Maejima, T; Ohno-Shosaku, T; Kano, M
      Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals

      NEUROSCIENCE RESEARCH
    30. Tsai, SJ; Wang, YC; Hong, CJ
      Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders

      AMERICAN JOURNAL OF MEDICAL GENETICS
    31. Huang, W; Moody, DE; Andrenyak, DM; Smith, EK; Foltz, RL; Huestis, MA; Newton, JF
      Simultaneous determination of Delta(9)-tetrahydrocannabinol and 11-nor-9-Carboxy-Delta(9)-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry

      JOURNAL OF ANALYTICAL TOXICOLOGY
    32. Lallemand, F; Soubrie, PH; De Witte, PH
      Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    33. Gurwitz, D; Weizman, A
      Fatty acid amide hydrolase inhibitors and the marijuana debate

      LANCET
    34. Koch, JE
      Delta(9)-THC stimulates food intake in Lewis rats - Effects on chow, high-fat and sweet high-fat diets

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    35. Patricelli, MP; Cravatt, BF
      Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides

      VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 62
    36. Quistad, CB; Sparks, SE; Casida, JE
      Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    37. Liddle, J; Huffman, JW
      Enantioselective synthesis of 11-hydroxy-(1 ' S,2 ' R)-dimethylheptyl-Delta(8)-THC, a very potent CB1 agonist

      TETRAHEDRON
    38. Chapman, V
      Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats

      NEUROPHARMACOLOGY
    39. Lamarque, S; Taghzouti, K; Simon, H
      Chronic treatment with Delta(9)-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction

      NEUROPHARMACOLOGY
    40. Campbell, VA
      Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation

      NEUROPHARMACOLOGY
    41. Corchero, J; Manzanares, J; Fuentes, JA
      Role of gonadal steroids in the corticotropin-releasing hormone and proopiomelanocortin gene expression response to Delta(9)-tetrahydrocannabinol in the hypothalamus of the rat

      NEUROENDOCRINOLOGY
    42. Granberg, M; Fowler, CJ; Jacobsson, SOP
      Effects of the cannabimimetic fatty acid derivatives 2-arachidonoylglycerol, anandamide, palmitoylethanolamide and methanandamide upon IgE-dependent antigen-induced beta-hexosaminidase, serotonin and TNF alpha release from rat RBL-2H3 basophilic leukaemia cells

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    43. Di Marzo, V; Goparaju, SK; Wang, L; Liu, J; Batkai, S; Jarai, Z; Fezza, F; Miura, GI; Palmiter, RD; Sugiura, T; Kunos, G
      Leptin-regulated endocannabinoids are involved in maintaining food intake

      NATURE
    44. Mani, SK; Mitchell, A; O'Malley, BW
      Progesterone receptor and dopamine receptors are required in Delta(9)-tetrahydrocannabinol modulation of sexual receptivity in female rats

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    45. Berger, A; Crozier, G; Bisogno, T; Cavaliere, P; Innis, S; Di Marzo, V
      Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    46. Chou, KJ; Tseng, LL; Cheng, JS; Wang, JL; Fang, HC; Lee, KC; Su, W; Law, YP; Jan, CR
      CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells

      LIFE SCIENCES
    47. De Petrocellis, L; Harrison, S; Bisogno, T; Tognetto, M; Brandi, I; Smith, GD; Creminon, C; Davis, JB; Geppetti, P; Di Marzo, V
      The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase

      JOURNAL OF NEUROCHEMISTRY
    48. Selley, DE; Rorrer, WK; Breivogel, CS; Zimmer, AM; Zimmer, A; Martin, BR; Sim-Selley, LJ
      Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation

      JOURNAL OF NEUROCHEMISTRY
    49. Tetko, IV; Kovalishyn, VV; Livingstone, DJ
      Volume learning algorithm artificial neural networks for 3D QSAR studies

      JOURNAL OF MEDICINAL CHEMISTRY
    50. Ikemoto, A; Ohishi, M; Sato, Y; Hata, N; Misawa, Y; Fujii, Y; Okuyama, H
      Reversibility of n-3 fatty acid deficiency-induced alterations of learningbehavior in the rat: level of n-6 fatty acids as another critical factor

      JOURNAL OF LIPID RESEARCH
    51. Huang, SM; Bisogno, T; Petros, TJ; Chang, SY; Zavitsanos, PA; Zipkin, RE; Sivakumar, R; Coop, A; Maeda, DY; De Petrocellis, L; Burstein, S; Di Marzo, V; Walker, JM
      Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. Ueda, N; Yamanaka, K; Yamamoto, S
      Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance

      JOURNAL OF BIOLOGICAL CHEMISTRY
    53. De Petrocellis, L; Bisogno, T; Maccarrone, M; Davis, JB; Finazzi-Agro, A; Di Marzo, V
      The activity of anandamide at vanilloid VR1 receptors requires facilitatedtransport across the cell membrane and is limited by intracellular metabolism

      JOURNAL OF BIOLOGICAL CHEMISTRY
    54. Kurihara, J; Nishigaki, M; Suzuki, S; Okubo, Y; Takata, Y; Nakane, S; Sugiura, T; Waku, K; Kato, H
      2-Arachidonoylglycerol norepinephrine release and anandamide oppositely modulate from the rat heart sympathetic nerves

      JAPANESE JOURNAL OF PHARMACOLOGY
    55. Karava, V; Fasia, L; Siafaka-Kapadai, A
      Anandamide amidohydrolase activity, released in the medium by Tetrahymena pyriformis. Identification and partial characterization

      FEBS LETTERS
    56. De Petrocellis, L; Davis, JB; Di Marzo, V
      Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

      FEBS LETTERS
    57. Feng, WK; Song, ZH
      Functional roles of the tyrosine within the NP(X)(n)Y motif and the cysteines in the C-terminal juxtamembrane region of the CB2 cannabinoid receptor

      FEBS LETTERS
    58. da Silva, GE; Morato, GS; Takahashi, RN
      Rapid tolerance to Delta(9)-tetrahydrocannabinol and cross-tolerance between ethanol and Delta(9)-tetrahydrocannabinol in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Serra, S; Carai, MAM; Brunetti, G; Gomez, R; Melis, S; Vacca, G; Colombo, G; Gessa, GL
      The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behavior in alcohol-preferring rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Darmani, NA
      The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemeticand motor depressant actions of WIN 55, 212-2

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Wallace, MJ; Wiley, JL; Martin, BR; DeLorenzo, RJ
      Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects

      EUROPEAN JOURNAL OF PHARMACOLOGY
    62. Sprague, J; Harrison, C; Rowbotham, DJ; Smart, D; Lambert, DG
      Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide

      EUROPEAN JOURNAL OF PHARMACOLOGY
    63. Wagner, JA; Jarai, Z; Batkai, S; Kunos, G
      Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    64. Lee, SF; Newton, C; Widen, R; Friedman, H; Klein, TW
      Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    65. Acquas, E; Pisanu, A; Marrocu, P; Goldberg, SR; Di Chiara, G
      Delta(9)-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

      EUROPEAN JOURNAL OF PHARMACOLOGY
    66. Calignano, A; La Rana, G; Piomelli, D
      Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide

      EUROPEAN JOURNAL OF PHARMACOLOGY
    67. Fride, E; Ginzburg, Y; Breuer, A; Bisogno, T; Di Marzo, V; Mechoulam, R
      Critical role of the endogenous cannabinoid system in mouse pup suckling and growth

      EUROPEAN JOURNAL OF PHARMACOLOGY
    68. Siegling, A; Hofmann, HA; Denzer, D; Mauler, F; De Vry, J
      Cannabinoid CB1 receptor upregulation in a rat model of chronic neuropathic pain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    69. Sim-Selley, LJ; Brunk, LK; Selley, DE
      Inhibitory effects of SR141716A on G-protein activation in rat brain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    70. Manzoni, OJ; Bockaert, J
      Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens

      EUROPEAN JOURNAL OF PHARMACOLOGY
    71. Mukhopadhyay, S; Howlett, AC
      CB1 receptor-C protein association - Subtype selectivity is determined by distinct intracellular domains

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    72. Tanaka, T; Morishige, J; Takimoto, T; Takai, Y; Satouchi, K
      Metabolic characterization of sciadonic acid (5c,11c,14c-eicosatrienoic acid) as an effective substitute for arachidonate of phosphatidylinositol

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    73. Lambert, DM; Vandevoorde, S; Diependaele, G; Govaerts, SJ; Robert, AR
      Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice

      EPILEPSIA
    74. Ripamonti, C; Dickerson, ED
      Strategies for the treatment of cancer pain in the new millennium

      DRUGS
    75. Niederhoffer, N; Hansen, HH; Fernandez-Ruiz, JJ; Szabo, B
      Effects of cannabinoids on adrenaline release from adrenal medullary cells

      BRITISH JOURNAL OF PHARMACOLOGY
    76. Capasso, R; Izzo, AA; Fezza, F; Pinto, A; Capasso, F; Mascolo, N; Di Marzo, V
      Inhibitory effect of palmitoylethanolamide on gastrointestinal motility inmice

      BRITISH JOURNAL OF PHARMACOLOGY
    77. White, R; Ho, WSV; Bottrill, FE; Ford, WR; Hiley, CR
      Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries

      BRITISH JOURNAL OF PHARMACOLOGY
    78. Savinainen, JR; Jarvinen, T; Laine, K; Laitinen, JT
      Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes

      BRITISH JOURNAL OF PHARMACOLOGY
    79. Bagate, K; Grima, M; Imbs, JL; De Jong, W; Helwig, JJ; Barthelmebs, M
      Signal transduction pathways involved in kinin B-2 receptor-mediated vasodilation in the rat isolated perfused kidney

      BRITISH JOURNAL OF PHARMACOLOGY
    80. Christopoulos, A; Wilson, K
      Interaction of anandamide with the M-1 and M-4 muscarinic acetylcholine receptors

      BRAIN RESEARCH
    81. Monhemius, R; Azami, J; Green, DL; Roberts, MHT
      CB1 receptor mediated analgesia from the Nucleus Reticularis Gigantocellularis pars alpha is activated in an animal model of neuropathic pain

      BRAIN RESEARCH
    82. Moody, JS; Kozak, KR; Ji, C; Marnett, LJ
      Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase

      BIOCHEMISTRY
    83. Patricelli, MP; Cravatt, BF
      Characterization and manipulation of the acyl chain selectivity of fatty acid amide hydrolase

      BIOCHEMISTRY
    84. Fowler, CJ; Jonsson, KO; Tiger, G
      Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide

      BIOCHEMICAL PHARMACOLOGY
    85. Ramer, R; Brune, K; Pahl, A; Hinz, B
      R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    86. Farquhar-Smith, WP; Rice, ASC
      Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder

      ANESTHESIOLOGY
    87. Di Marzo, V; Bisogno, T; De Petrocellis, L
      Anandamide: some like it hot

      TRENDS IN PHARMACOLOGICAL SCIENCES
    88. Cadoni, C; Pisanu, A; Solinas, M; Acquas, E; Di Chiara, G
      Behavioural sensitization after repeated exposure to Delta(9)-tetrahydrocannabinol and cross-sensitization with morphine

      PSYCHOPHARMACOLOGY
    89. Deroche-Gamonet, V; Le Moal, M; Piazza, PV; Soubrie, P
      SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats

      PSYCHOPHARMACOLOGY
    90. Varvel, SA; Hamm, RJ; Martin, BR; Lichtman, AH
      Differential effects of Delta(9)-THC on spatial reference and working memory in mice

      PSYCHOPHARMACOLOGY
    91. Fattore, L; Cossu, G; Martellotta, CM; Fratta, W
      Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats

      PSYCHOPHARMACOLOGY
    92. Earle, MJ; McCormac, PB; Seddon, KR
      The first high yield green route to a pharmaceutical in a room temperatureionic liquid

      GREEN CHEMISTRY
    93. Yagen, B; Burstein, S
      Novel and sensitive method for the detection of anandamide by the use of its dansyl derivative

      JOURNAL OF CHROMATOGRAPHY B
    94. Huffman, JW
      The search for selective ligands for the CB2 receptor

      CURRENT PHARMACEUTICAL DESIGN
    95. Di Marzo, V; Bisogno, T; De Petrocellis, L
      Endocannabinoids: New targets for drug development

      CURRENT PHARMACEUTICAL DESIGN
    96. Palmer, SL; Khanolkar, AD; Makriyannis, A
      Natural and synthetic endocannabinoids and their structure-activity relationships

      CURRENT PHARMACEUTICAL DESIGN
    97. Pertwee, RG
      Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    98. Goya, P; Jagerovic, N
      Recent advances in cannabinoid receptor agonists and antagonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    99. Kittler, JT; Grigorenko, EV; Clayton, C; Zhuang, SY; Bundey, SC; Trower, MM; Wallace, D; Hampson, R; Deadwyler, S
      Large-scale analysis of gene expression changes during acute and chronic exposure to Delta(9)-THC in rats

      PHYSIOLOGICAL GENOMICS
    100. Valverde, O; Ledent, C; Beslot, F; Parmentier, M; Roques, BP
      Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

      EUROPEAN JOURNAL OF NEUROSCIENCE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 03:15:35